Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-03-19 00:00:00 ET · period of report 2025-03-16 · accession 0001415889-25-008622 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-19 | 2025-03-16+ | KNSA | Ragosa Mark | CFO | M - OptEx | $12.97 | +21.2K | 34.8K | +156% | +$275.2K |
| D | 2025-03-19 | 2025-03-16 | KNSA | Ragosa Mark | CFO | F - Tax | $22.61 | -448 | 23.4K | -2% | -$10.1K |
| DM | 2025-03-19 | 2025-03-17+ | KNSA | Ragosa Mark | CFO | S - Sale+OE | $23.10 | -20.3K | 23.4K | -47% | -$469.9K |
| DM | 2025-03-19 | 2025-03-16+ | KNSA | Ragosa Mark | CFO | M - OptEx | $0.00 | -21.2K | 33.2K | -39% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-03-16 | M | A | 872 | — | 23,830 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. |
| 2 | Common | Class A Ordinary Share | 2025-03-16 | F | D | 448 | $22.61 | 23,382 | D | — | — | |
| 3 | Common | Class A Ordinary Share | 2025-03-19 | S | D | 8,879 | $23.10 | 23,382 | D | — | — | |
| 4 | Common | Class A Ordinary Share | 2025-03-17 | S | D | 11,464 | $23.10 | 23,382 | D | — | — | (F3) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $23.10 and $23.13. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 5 | Common | Class A Ordinary Share | 2025-03-19 | M | A | 8,879 | $12.97 | 32,261 | D | — | — | |
| 6 | Common | Class A Ordinary Share | 2025-03-17 | M | A | 11,464 | $12.97 | 34,846 | D | — | — | |
| 7 | Derivative | Restricted Share Unit | 2025-03-16 | M | D | 872 | $0.00 | 0 | D | — · — to — | 872 Class A Ordinary Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F4) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 16, 2021. |
| 8 | Derivative | Share Option | 2025-03-19 | M | D | 8,879 | $0.00 | 24,318 | D | $12.97 · — to 2031-09-01 | 8,879 Class A Ordinary Share | (F5) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 2, 2021. |
| 9 | Derivative | Share Option | 2025-03-17 | M | D | 11,464 | $0.00 | 33,197 | D | $12.97 · — to 2031-09-01 | 11,464 Class A Ordinary Share | (F5) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 2, 2021. |